Murugesan Velayutham

Dr. Murugesan Velayutham

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
TLTengfang Li
Tengfang Li
ZZZhongqiang Zhang
Zhongqiang Zhang
JBJoe G. Bartolacci
Joe G. Bartolacci
GDGaelen K. Dwyer
Gaelen K. Dwyer
QLQuan Liu
Quan Liu
HTHēth R. Turnquist
Hēth R. Turnquist
Alarmins, sequestered self-molecules containing damage-associated molecular patterns, are released during tissue injury to drive innate immune cell proinflammatory responses. Whether endogenous negative regulators controlling early immune responses are also released at the site of injury is poorly understood. Herein, we establish that the stromal cell–derived alarmin interleukin 33 (IL-33) is a local factor that directly restricts the proinflammatory capacity of graft-infiltrating macrophages early after transplantation. By assessing heart transplant recipient samples and using a mouse heart transplant model, we establish that IL-33 is upregulated in allografts to limit chronic rejection. Mouse cardiac transplants lacking IL-33 displayed dramatically accelerated vascular occlusion and subsequent fibrosis, which was not due to altered systemic immune responses. Instead, a lack of graft IL-33 caused local augmentation of proinflammatory iNOS+ macrophages that accelerated graft loss. IL-33 facilitated a metabolic program in macrophages associated with reparative and regulatory functions, and local delivery of IL-33 prevented the chronic rejection of IL-33–deficient cardiac transplants. Therefore, IL-33 represents what we believe is a novel regulatory alarmin in transplantation that limits chronic rejection by restraining the local activation of proinflammatory macrophages. The local delivery of IL-33 in extracellular matrix–based materials may be a promising biologic for chronic rejection prophylaxis.

21 November 2023 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
NTNhat Anh Thieu
Nhat Anh Thieu
Wei LiWei Li
Wei Li
XCXiujuan Chen
Xiujuan Chen
QLQingyuan Li
Qingyuan Li
QWQingsong Wang
Qingsong Wang
XLXingbo Liu
Xingbo Liu
Recently, aqueous zinc-ion batteries (ZIBs) have become increasingly attractive as grid-scale energy storage solutions due to their safety, low cost, and environmental friendliness. However, severe dendrite growth, self-corrosion, hydrogen evolution, and irreversible side reactions occurring at Zn anodes often cause poor cyclability of ZIBs. This work develops a synergistic strategy to stabilize the Zn anode by introducing a molybdenum dioxide coating layer on Zn (MoO2@Zn) and Tween 80 as an electrolyte additive. Due to the redox capability and high electrical conductivity of MoO2, the coating layer can not only homogenize the surface electric field but also accommodate the Zn2+ concentration field in the vicinity of the Zn anode, thereby regulating Zn2+ ion distribution and inhibiting side reactions. MoO2 coating can also significantly enhance surface hydrophilicity to improve the wetting of electrolyte on the Zn electrode. Meanwhile, Tween 80, a surfactant additive, acts as a corrosion inhibitor, preventing Zn corrosion and regulating Zn2+ ion migration. Their combination can synergistically work to reduce the desolvation energy of hydrated Zn ions and stabilize the Zn anodes. Therefore, the symmetric cells of MoO2@Zn∥MoO2@Zn with optimal 1 mM Tween 80 additive in 1 M ZnSO4 achieve exceptional cyclability over 6000 h at 1 mA cm-2 and stability (>700 h) even at a high current density (5 mA cm-2). When coupling with the VO2 cathode, the full cell of MoO2@Zn∥VO2 shows a higher capacity retention (82.4%) compared to Zn∥VO2 (57.3%) after 1000 cycles at 5 A g-1. This study suggests a synergistic strategy of combining surface modification and electrolyte engineering to design high-performance ZIBs.

21 March 2024 in ACS Energy Letters
Verified
Journal Article
Open access
XCXiujuan Chen
Xiujuan Chen
PGPeiyuan Gao
Peiyuan Gao
Wei LiWei Li
Wei Li
NTNhat Anh Thieu
Nhat Anh Thieu
ZGZane M. Grady
Zane M. Grady
XLXingbo Liu
Xingbo Liu
Aqueous Zn-based electrochemical technologies hold promise for large-scale energy storage applications, yet challenges persist in the unsatisfied Zn reversibility arising from an unstable Zn/electrolyte interface. Here, we employ molecular interface engineering using amphiphilic Pluronic triblock copolymers as electrolyte additives to stabilize the Zn anodes. With a balanced hydrophilic–hydrophobic nature, Pluronic F127 adsorbed on the Zn surface constructs a hydrodynamic interphase, where the hydrophobic PPO center shields the Zn surface from water-induced side reactions, while PEO side blocks guide the homogeneous Zn2+ redistribution. Additionally, F127 contributes to the Zn2+ solvation structure to weaken the water activity at the interfacial region. As a result, F127 additive enables cycling durability over 9300 and 3100 h at 1 and 5 mA cm–2, respectively, and considerable cyclability with high-capacity retention across a wide current density range in Zn||VO2 full cells. This study highlights the potential of amphiphilic block copolymers in stabilizing metallic anode interfaces in aqueous electrolytes.

8 May 2021 in Molecules
Verified
Journal Article
Open access
PDF file
MVMurugesan Velayutham
Murugesan Velayutham
MPMartin Poncelet
Martin Poncelet
Tim EubankTim Eubank
Tim Eubank
BDBenoit Driesschaert
Benoit Driesschaert
VKValery Khramtsov
Valery Khramtsov
Alterations in viscosity of biological fluids and tissues play an important role in health and diseases. It has been demonstrated that the electron paramagnetic resonance (EPR) spectrum of a 13C-labeled trityl spin probe (13C-dFT) is highly sensitive to the local viscosity of its microenvironment. In the present study, we demonstrate that X-band (9.5 GHz) EPR viscometry using 13C-dFT provides a simple tool to accurately measure the microviscosity of human blood in microliter volumes obtained from healthy volunteers. An application of low-field L-band (1.2 GHz) EPR with a penetration depth of 1–2 cm allowed for microviscosity measurements using 13C-dFT in the living tissues from isolated organs and in vivo in anesthetized mice. In summary, this study demonstrates that EPR viscometry using a 13C-dFT probe can be used to noninvasively and rapidly measure the microviscosity of blood and interstitial fluids in living tissues and potentially to evaluate this biophysical marker of microenvironment under various physiological and pathological conditions in preclinical and clinical settings.

1 May 1997 in Journal of Molecular Catalysis A: Chemical
Verified
Journal Article
Closed access
SES.P. Elangovan
S.P. Elangovan
MVMurugesan Velayutham
Murugesan Velayutham

23 November 2024 in Chemical & Biomedical Imaging
Verified
Journal Article
Open access
MVMurugesan Velayutham
Murugesan Velayutham
MPMartin Poncelet
Martin Poncelet
AEAyano Enomoto
Ayano Enomoto
JHJustin L. Huffman
Justin L. Huffman
VPVirat G. Pandya
Virat G. Pandya
BDBenoit Driesschaert
Benoit Driesschaert
Enzyme catalytic activities are critical biomarkers of tissue states under physiological and pathophysiological conditions. However, the direct measurement and imaging of enzyme activity in vivo remains extremely challenging. We report the synthesis and characterization of the first stable triarylmethyl (TAM) radical substrate of alkaline phosphatase (TAM-ALPs). The enzymatic dephosphorylation of TAM-ALPs results in a drastic change in its electron paramagnetic resonance (EPR) spectrum that can be used to image enzyme activity using EPR-based technologies. TAM-ALPs and their enzyme products were fully characterized using EPR and HPLC-MS techniques. A proof of concept of imaging enzyme activity using Overhauser-enhanced magnetic resonance imaging was demonstrated in vitro. This study clearly demonstrates the potential of EPR-based imaging technologies associated with TAM spin probes to map enzyme activity in vivo in future studies.